
SAME
Detail Analisis & Profil Saham
Skor Sentimen Berita
50
Netral
Rp 300
▼ Rp 6-1.96%
Deep AI Analysis
AI sedang menyusun analisis mendalam untuk SAME...
Analisis AI Belum Tersedia
Klik tombol "Perbarui Analisis" di atas untuk men-generate analisis teknikal dan fundamental secara instan.
Tentang Perusahaan
PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company operates specialty centers. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.
Jajaran Direksi
Mr. Jusup Halimi M.B.A.
President Director & CEO
Mr. Armen Antonius Djan
Finance Director, CFO & Director
Ms. . Nailufar
Head of Sales & Marketing and Director
Bambang Syumanjaya
HR Director
Dr. Meta Dewi Thedja M.D., Ph.D.
Medical Director & Director
Dr. G. A. Kusmiati
Special Project Director & Director
Struktur Kepemilikan
88.99%
Dimiliki Insiders
0.13%
Dimiliki Institusi
3
Jumlah Institusi
Valuasi Utama
PER
263.16
PBV
1.35
MarketCap
5.15 T
DividendYield
N/A
Valuation_Status
Overvalued
Data Keuangan & Metrik
Total Pendapatan
1900.20 M
EBITDA
346.27 M
Total Utang
1080.07 M
Kas Total
174.20 M
Gross Margin
28.55%
Profit Margin
1.04%
ROE
0.66%
ROA
1.16%
Indikator Momentum
RSI (14)
41
Neutral
MACD Status
Bearish Momentum
Support (30D)
280
Resistance (30D)
416
Volume & Tren MA
Volume Status (14D)
Normal
Moving Average (20)
332
Moving Average (50)
325
Weak Uptrend
Berita Terkini
Sarana Meditama (SAME) Dapatkan Fasilitas Kredit Rp 4 Triliun
Netral (50)
KONTAN Investasi on MSN•8/7/2026
Sarana Meditama (SAME) Akuisisi 28% Saham Jakarta Eye Center
Netral (50)
economy.okezone•26/4/2022
BEI hentikan sementara perdagangan saham SAME
Netral (50)
Antara News•11/2/2013
Akhir Pekan, Saham SAME Melesat 50 Persen
Netral (50)
TribunNews•10/1/2013
Tidak ada berita Nasional terbaru.
Tidak ada berita Global terbaru.